By supporting weight management and metabolic health, these therapies may positively impact risk factors associated with conditions like COVID-19 and heart disease
Telegra MD is referenced as identified on Zevay's own site and is not owned by or affiliated with the publisher of this article
In a multicenter double-blind RCT, long-term oral BCAA supplementation significantly reduced the composite risk of death, liver transplantation, and disease progression in patients with advanced cirrhosis compared with lactalbumin or maltodextrin controls, with event-free survival significantly improved in the BCAA group (9)
When included as part of a holistic treatment plan, GLP-1 shots shows promise for both children and adults struggling with excess weight
At this time there is no conclusive evidence that GLP-1 medications directly damage the microbiome, but changes in appetite, meal size, and food variety can influence microbial diversity over time